NuTech NuCel: A Prospective, Efficacy Study of NuCel in Patients Undergoing Fusion for One, Two or Three Level Degenerative Disease of the Lumbar Spine.
Phase of Trial: Phase II
Latest Information Update: 22 Aug 2016
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Intervertebral disc degeneration
- Focus Therapeutic Use
- Sponsors Nutech Medical
- 11 Aug 2016 Planned End Date changed from 1 Jul 2017 to 1 Jan 2018.
- 11 Aug 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Nov 2017.
- 13 Apr 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2016 to 1 Jul 2017.